GlycoEra
Last verified 2026-05-21. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $130.0Mattributed |
|---|---|
| Latest round | series-b, $130.0M, 2025-05-01attributed |
| Founded | unknown |
| Headquarters | CH |
| Industry | bio |
| Stage | series-b+ |
| Website | glycoera.com |
GlycoEra develops biologics that selectively degrade circulating proteins, particularly the pathogenic IgG4 autoantibodies driving autoimmune disease. It targets patients who benefit from early, precise intervention, led by GE8820. Unlike broad immunosuppressants, it degrades targets deeply without dampening the wider immune system.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-05-01 | series-b | $130.0M | undisclosed |
Detected tech stack
Cloudflare, WordPress 6.9.4, Magnific Popup 4.9.1, GoDaddy CoBlocks, Slick, jQuery Migrate 3.4.1, Cloudflare Bot Management, Contact Form 7 5.9.3, web-vitals, WP Job Openings 3.4.6, Bold Page Builder, PHP
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series B, $130.0M | attributed | sifted named as publisher. No document URL on file. |
| Total raised $130.0M | attributed | sifted named as publisher. No document URL on file. |
| Company existence | self-reported | glycoera.com, read 2026-05-21 |
| Description | self-reported | glycoera.com, read 2026-05-21 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.